# MEDICE

MEDICE is a Corporate Investor based in Iserlohn, Germany.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Iserlohn, Germany
- **Region:** Europe
- **Address:** Kuhloweg 37, 58638 Iserlohn, Germany
- **Founded:** 1949
- **Assets under management:** Undisclosed
- **Website:** medice.com
- **LinkedIn:** https://www.linkedin.com/company/medice-the-health-family

## Regulatory record

- **Reports private funds:** No

## About

MEDICE was founded in 1949 in Iserlohn, Germany, and remains entirely family-owned under the third generation of the Ammer and Pütter families. Managing Partners Dr. Richard Ammer and Dr. Katja Pütter-Ammer lead the group as both an operating pharmaceutical company and a corporate investment platform. The firm pursues a multi-asset healthcare strategy focused on pharmaceutical products, digital therapeutics, and nutritional health concepts. Its investment approach leans heavily on direct corporate venture participation within the European healthcare ecosystem. Confirmed positions or co-investments include the digital therapeutic Selfapy, backed alongside healthcare specialist SHS Capital. Strategic licensing partnerships extend the group's pharmaceutical reach — a notable deal licenses Akebia Therapeutics' Vafseo for European markets. Geographic coverage centers on Germany and broader European healthcare markets from its operational base in North Rhine-Westphalia. The group operates principal production and distribution from its Iserlohn headquarters, with an additional industrial production site in Salzgitter-Ringelheim expanded through ongoing site investments. Professional team data is not publicly disclosed, though the firm maintains active industry governance participation — Dr. Richard Ammer serves as Vice President of the German Pharmaceutical Association (BPI). The operating footprint includes a monitored ecological initiative, the Iserlohn Flowering Meadows, and an associated Health Family Shop retail venture. MEDICE's structural differentiator lies in its hybrid architecture: a fully integrated pharmaceutical manufacturer simultaneously deploying corporate balance-sheet capital into early-stage and growth healthcare ventures. The link between its regulated drug production, European licensing arrangements, and venture co-investments creates a feedback loop — new therapies enter its commercial pipeline while corporate development capital backs adjacent digital and nutritional health founders.

## Sectors

- Healthcare Services
- Digital Health
- Pharmaceuticals & Therapeutics

## People

- Dr. Richard Ammer — Managing Partner and CEO
- Dr. Katja Pütter-Ammer — Managing Partner and 3rd generation owner

## Questions

### Who runs investment decisions at MEDICE?

Investment decisions sit with the family-led management. Dr. Richard Ammer acts as Managing Partner and CEO, with Dr. Katja Pütter-Ammer serving as Managing Partner and third-generation owner. Their dual oversight combines operational pharmaceutical leadership with capital allocation.

### How does MEDICE source proprietary deal flow?

Deal flow is sourced through the group's pharmaceutical licensing network, industry relationships, and co-investment partnerships. Its role as a European licensee for therapies such as Akebia Therapeutics' Vafseo creates direct pipeline visibility into biotech innovation.

### Does MEDICE participate in fund commitments or only direct deals?

Known activity is concentrated in direct corporate venture investments and co-investments alongside specialists such as SHS Capital in deals like Selfapy. No fund-of-fund commitments are publicly documented.

### Which sectors does MEDICE explicitly avoid?

MEDICE is anchored to human health — physical and mental pharmaceutical therapies, digital treatments, and nutritional health. It does not invest outside healthcare, nor has it disclosed activity in sectors such as enterprise software, industrials, or fintech.

## Related profiles

- [Medical Technology Venture Partners](https://altss.com/profile/medical-technology-venture-partners)
- [Medici Capital Partners](https://altss.com/profile/medici-capital-partners)

---

Last updated: 2026-08-10T18:03:08.091Z

Canonical page: https://altss.com/profile/medice

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology